These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 9377071

  • 21. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 22. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
    Litzow MR, Brashem-Stein C, Andrews RG, Bernstein ID.
    Blood; 1991 Jun 01; 77(11):2354-9. PubMed ID: 1710150
    [Abstract] [Full Text] [Related]

  • 23. In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells.
    Lefebvre P, Winter JN, Rademaker AW, Goolsby C, Cohen I.
    Stem Cells; 1997 Jun 01; 15(2):112-8. PubMed ID: 9090787
    [Abstract] [Full Text] [Related]

  • 24. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Bender JG, Unverzagt KL, Maples PB, Mehrotra Y, Mellon J, Van Epps DE, Stewart CC.
    Exp Hematol; 1992 Oct 01; 20(9):1135-40. PubMed ID: 1361455
    [Abstract] [Full Text] [Related]

  • 25. Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applications.
    Zimmerman TM, Bender JG, Lee WJ, Loudovaris M, Qiao X, Schilling M, Smith SL, Unverzagt K, Van Epps DE, Blake M, Williams DF, Williams SF.
    J Hematother; 1996 Jun 01; 5(3):247-53. PubMed ID: 8817391
    [Abstract] [Full Text] [Related]

  • 26. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR, Davies EG, Gibson FM, Gordon-Smith EC.
    Pediatr Res; 1995 May 01; 37(5):630-3. PubMed ID: 7541523
    [Abstract] [Full Text] [Related]

  • 27. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
    van de Ven C, Ishizawa L, Law P, Cairo MS.
    Exp Hematol; 1995 Nov 01; 23(12):1289-95. PubMed ID: 7589284
    [Abstract] [Full Text] [Related]

  • 28. Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils.
    Ema H, Suda T, Nagayoshi K, Miura Y, Civin CI, Nakauchi H.
    Blood; 1990 Nov 15; 76(10):1956-61. PubMed ID: 1700728
    [Abstract] [Full Text] [Related]

  • 29. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C, Delforge A, Bron D, Ley P, de Hemptinne D, Stryckmans P.
    Stem Cells; 1994 Nov 15; 12(6):616-25. PubMed ID: 7533580
    [Abstract] [Full Text] [Related]

  • 30. The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist.
    Abegg AL, Vickery LE, Bremer ME, Donnelly AM, Doshi PD, Evans ML, Thurman TL, Braford SR, Caparon MH, Bauer SC, Giri JG, Welply JK, McKearn JP, Smith WG.
    Leukemia; 2002 Mar 15; 16(3):316-26. PubMed ID: 11896534
    [Abstract] [Full Text] [Related]

  • 31. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
    Teofili L, Iovino MS, Di Mario A, Ortu La Barbera E, Pierelli L, Bussa S, Rumi C, Menichella G, Leone G.
    Int J Artif Organs; 1993 Dec 15; 16 Suppl 5():89-95. PubMed ID: 7516922
    [Abstract] [Full Text] [Related]

  • 32. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
    Ho AD, Young D, Maruyama M, Corringham RE, Mason JR, Thompson P, Grenier K, Law P, Terstappen LW, Lane T.
    Exp Hematol; 1996 Nov 15; 24(13):1460-8. PubMed ID: 8950228
    [Abstract] [Full Text] [Related]

  • 33. Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.
    Bishop MR, Jackson JD, O'Kane-Murphy B, Schmit-Pokorny K, Vose JM, Bierman PJ, Warkentin PI, Armitage JO, Garrison L, Kessinger A.
    J Clin Oncol; 1996 Sep 15; 14(9):2521-6. PubMed ID: 8823331
    [Abstract] [Full Text] [Related]

  • 34. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
    Vadhan-Raj S.
    Stem Cells; 1994 May 15; 12(3):253-61. PubMed ID: 8075592
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34+ cord blood.
    Cairo MS, Law P, van de Ven C, Plunkett JM, Williams D, Ishizawa L, Gee A.
    Pediatr Res; 1992 Sep 15; 32(3):277-81. PubMed ID: 1383918
    [Abstract] [Full Text] [Related]

  • 37. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S, Meister B, Bühring HJ, Baum CM, Mc Kearn JP, Bock T, Kanz L, Brugger W.
    Exp Hematol; 2000 Apr 15; 28(4):460-70. PubMed ID: 10781904
    [Abstract] [Full Text] [Related]

  • 38. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
    Strauss LC, Welsh SB, Civin CI.
    Exp Hematol; 1991 Sep 15; 19(8):734-41. PubMed ID: 1714400
    [Abstract] [Full Text] [Related]

  • 39. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T, Muroi K, Tomizuka H, Amemiya Y, Miura Y.
    Stem Cells; 1995 May 15; 13(3):273-80. PubMed ID: 7542113
    [Abstract] [Full Text] [Related]

  • 40. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
    Sawada K, Sato N, Tarumi T, Sakai N, Koizumi K, Sakurama S, Ieko M, Yasukouchi T, Koyanagawa Y, Yamaguchi M.
    Br J Haematol; 1993 Mar 15; 83(3):349-58. PubMed ID: 7683482
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.